Prostate specific antigen — brief update on its clinical use
Prostate specific antigen (PSA) testing of asymptomatic men enables the diagnosis of localised prostate cancer which in potentially curable, but it also poses certain risks. Doctors run the risk of litigation for failure to diagnose cancer at a curable stage, while patients run the risk of being dia...
Saved in:
| Main Authors: | Christiaan F. Heyns, André van der Merwe |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AOSIS
2008-04-01
|
| Series: | South African Family Practice |
| Subjects: | |
| Online Access: | https://safpj.co.za/index.php/safpj/article/view/1100 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Usefulness of prostate specific antigen density in detecting prostate carcinoma: A hospital-based study in patients with prostate biopsies
by: Reshmi Shrestha, et al.
Published: (2022-03-01) -
Benign prostatic hyperplasia and prostate-specific antigen
by: Pejčić Tomislav, et al.
Published: (2015-01-01) -
Advanced prostatic carcinomas with low serum levels of prostate-specific antigen
by: Cerović Snežana J., et al.
Published: (2002-01-01) -
Optimal use of prostate specific antigen for prostate cancer screening
by: Miočinović Ranko, et al.
Published: (2013-01-01) -
Potential clinical application of the cancer antigen CA‑62 for differential diagnosis of prostate cancer and benign prostatic hyperplasia at the elevated prostate‑specific antigen
by: Zh. R. Cherkasova, et al.
Published: (2023-03-01)